Pre-exposure prophylaxis (PrEP)

URI: https://gptkb.org/entity/Pre-exposure_prophylaxis_(PrEP)
GPTKB entity
Statements (30)
Predicate Object
gptkbp:instanceOf gptkb:medical_intervention
gptkbp:administeredBy oral medication
injectable medication
gptkbp:alternativeName gptkb:PrEP
pre-exposure prophylaxis
gptkbp:approvalYear 2012
gptkbp:approvedBy gptkb:U.S._Food_and_Drug_Administration
gptkbp:commonHealthIssues gptkb:cabotegravir
tenofovir alafenamide/emtricitabine
tenofovir disoproxil fumarate/emtricitabine
gptkbp:contraindication severe kidney disease
HIV-positive individuals
gptkbp:effect over 90% when taken as prescribed
gptkbp:frequency daily (oral)
every 2 months (injectable)
gptkbp:notEffectiveAgainst pregnancy
other sexually transmitted infections
gptkbp:recommendation gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
gptkbp:requires medical follow-up
regular HIV testing
gptkbp:sideEffect nausea
headache
kidney function changes
bone density loss
gptkbp:targetAudience people at high risk of HIV infection
gptkbp:usedFor HIV prevention
gptkbp:bfsParent gptkb:Sida
gptkbp:bfsLayer 7
https://www.w3.org/2000/01/rdf-schema#label Pre-exposure prophylaxis (PrEP)